Ukraine | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Ukraine totalled $ 278 million in 2023. Sales of commodity group 30 from Ukraine went up by 16.7% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 40 million (cumulative exports of commodity group 30 from Ukraine amounted $238 million in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 0.77% of total exports from Ukraine (cumulative merchandise exports from Ukraine totalled $ 36 billion in 2023). The share of commodity group 30 in total exports from Ukraine increased by 0.233 p.p. compared to 2022 (it was 0.536% in 2022 and cumulative exports from Ukraine were equal to $ 44 billion).
Where does Ukraine export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Ukraine in 2023:
- Uzbekistan with a share of 19.1% (53 million US$)
- Lithuania with a share of 13.6% (38 million US$)
- Kazakhstan with a share of 10% (28 million US$)
- Georgia with a share of 8.92% (24 million US$)
- Moldova with a share of 5.46% (15.2 million US$)
- Iraq with a share of 5.36% (14.9 million US$)
- Azerbaijan with a share of 5.04% (14 million US$)
- Kyrgyz Republic with a share of 3.66% (10.2 million US$)
- Switzerland with a share of 3.04% (8.47 million US$)
- Mexico with a share of 2.52% (7.03 million US$)
Exports structure of 30 - Pharmaceutical products - from Ukraine in 2023 represented by the following main commodity groups:
- 77% (217 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 16.8% (46 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 3.26% (9.1 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 1.45% (4.06 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.318% (887 thousand US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.255% (711 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Ukraine totalled $ 2.14 billion in 2023. Sales of commodity group 30 to Ukraine went up by 12.7% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 241 million (the value of imports of commodity group 30 to Ukraine was equal to $1.9 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 3.36% of total import flow to Ukraine (in 2023, total imports to Ukraine amounted to $ 63 billion). The share of commodity group 30 in total imports to Ukraine decreased by 0.071 p.p. compared to 2022 (it was 3.44% in 2022 and cumulative imports to Ukraine were equal to $ 55 billion).
Where does Ukraine import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Ukraine in 2023:
- Germany with a share of 19.3% (414 million US$)
- India with a share of 8.61% (184 million US$)
- France with a share of 8.28% (177 million US$)
- Italy with a share of 6.89% (147 million US$)
- USA with a share of 4.7% (100 million US$)
- Spain with a share of 4.65% (99 million US$)
- Slovenia with a share of 4.39% (94 million US$)
- Ireland with a share of 4.16% (89 million US$)
- Switzerland with a share of 3.23% (69 million US$)
- Hungary with a share of 3.18% (68 million US$)
Imports structure of 30 - Pharmaceutical products - to Ukraine in 2023 represented by the following main commodity groups:
- 80% (1.72 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 13.7% (295 million US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 3.49% (74 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 1.09% (23 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.715% (15.3 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
- 0.483% (10.3 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
